首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model
【24h】

Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model

机译:I型清道夫受体B类(SR-BI)调节阿尔茨海默病小鼠模型中的血管周巨噬细胞并改变淀粉样蛋白病理

获取原文
获取原文并翻译 | 示例
           

摘要

Scavenger receptor class B type I (SR-BI) is a high-density lipoprotein receptor that regulates cholesterol efflux from the peripheral tissues to the liver. SR-BI has been identified on astrocytes and vascular smooth muscle cells in Alzheimer's disease brain and has been shown to mediate adhesion of microglia to fibrillar amyloid-β (Aβ). Here we report that SR-BI mediates perivascular macrophage response and regulates Aβ-related pathology and cerebral amyloid angiopathy in an Alzheimer's mouse model. Reduction or deletion of SR-BI gene in heterozygous or homozygous deficient mice (SR-BI+/-,-/-) resulted in a significant increase in perivascular macrophages in the brain. SR-BI deletion had no effect on apolipoprotein E or apolipoprotein AI levels in the mouse brain. Our analysis revealed increased levels of SR-BI expression in the brains of human amyloid precursor protein (Swedish, Indiana) transgenic mice (J20 line). To evaluate the role of SR-BI in Alzheimer's disease pathogenesis, we inactivated one SR-BI allele in J20 transgenic mice. SR-BI reduction in J20/SR-BI+/- mice enhanced fibrillar amyloid deposition and cerebral amyloid angiopathy and also exacerbated learning and memory deficits compared with J20 littermates. Immunohistochemical analysis revealed localization of SR-BI on perivascular macrophages in tight association with Aβ deposits. Our data suggest that SR-BI reduction impairs the response of perivascular macrophages to Aβ and enhances the Aβ-related phenotype and cerebral amyloid angiopathy in J20 mice. These results reveal that SR-BI, a scavenger receptor primarily involved in high-density lipoprotein cholesterol transport, plays an essential role in Alzheimer's disease and cerebral amyloid angiopathy.
机译:B类清道夫受体(SR-BI)是一种高密度脂蛋白受体,可调节胆固醇从周围组织到肝脏的流出。 SR-BI已在阿尔茨海默氏病脑中的星形胶质细胞和血管平滑肌细胞上发现,并已证明可介导小胶质细胞与纤维状淀粉样β-(Aβ)的粘附。在这里,我们报道SR-BI介导血管周巨噬细胞反应,并调节Alzheimer小鼠模型中的Aβ相关病理和脑淀粉样血管病。杂合或纯合缺陷小鼠(SR-BI + /-,-/-)中SR-BI基因的减少或缺失导致大脑血管周巨噬细胞显着增加。 SR-BI删除对小鼠脑中的载脂蛋白E或载脂蛋白AI水平没有影响。我们的分析显示,人类淀粉样蛋白前体蛋白(瑞典,印第安纳州)转基因小鼠(J20系)的大脑中SR-BI表达水平增加。为了评估SR-BI在阿尔茨海默氏病发病机理中的作用,我们灭活了J20转基因小鼠中的一个SR-BI等位基因。与J20同窝仔相比,J20 / SR-BI +/-小鼠中SR-BI的降低增强了纤维状淀粉样蛋白沉积和脑淀粉样血管病,并加剧了学习和记忆障碍。免疫组织化学分析显示,SR-BI在血管周巨噬细胞上的定位与Aβ沉积紧密相关。我们的数据表明,SR-BI的降低损害了J20小鼠血管周巨噬细胞对Aβ的反应,并增强了Aβ相关表型和脑淀粉样血管病。这些结果表明,SR-BI是主要参与高密度脂蛋白胆固醇转运的清道夫受体,在阿尔茨海默氏病和脑淀粉样血管病中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号